NCT02586207 2025-10-07Pembrolizumab in Combination With CRT for LA-SCCHNSanford HealthPhase 1 Completed59 enrolled 9 charts
NCT00450138 2016-08-29Open Label, Phase I ZD6474 Head and Neck Cancer StudySanofiPhase 1 Completed48 enrolled
NCT00197444 2009-02-20Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal CancerHamamatsu UniversityPhase 2 Completed33 enrolled